Fouad Mikhail: Mechanical Thrombectomy and Anticoagulation in Intermediate-Risk Pulmonary Embolism
Fouad Mikhail, Sub-speciality Coordinator at NEGIDA Corporation, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Catheterization and Cardiovascular Interventions, adding:
“Honored to share that our original research has been accepted for publication in Catheterization and Cardiovascular Interventions (CCI) Impact Factor: 2.1 (SJR: 0.964 -Q1 in Cardiology and Cardiovascular Medicine).
In this work, we took a granular, risk-stratified approach to a clinically urgent question:
- In intermediate-risk PE, does mechanical thrombectomy offer a survival advantage over anticoagulation alone?
While MT was associated with lower 1-year mortality across both subgroups, the net clinical benefit differs sharply by risk profile—which may help refine patient selection for this rapidly adopted procedure.
- Large, real‑world cohort from a federated network of 165+ healthcare organizations
- Risk‑stratified design (low‑intermediate vs. high‑intermediate PE)
The paper is now published.
Special thanks to my dearest mentor that I have always learnt from .. Dr. Ahmed Abdelmaksoud and for my all time teammates Dr. Ali Dway and Dr. Abdulrahman El helbawy as well as our senior authors and all co‑authors for their invaluable contributions.”
Title: Mechanical Thrombectomy Versus Anticoagulation in Intermediate-Risk Pulmonary Embolism: A Risk-Stratified, Propensity Score–Matched Analysis
Authors: Fouad Hanna, Ahmed Abdelmaksoud, Ali Dway, Abdelrahman El-Helbawy, David C. Kaelber, Habib Rehman Khan, Noha Hammad, Amr Mohsen, Mina Basta
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology